Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "sales"
Home
GC Wellbeing’s Laennec Injection Clears Phase 3 Hurdle for IV Drip Use, Boosting Growth Prospects
GC Wellbeing announced on June 16 that it has secured topline results demonstrating that its chronic liver disease treatment, Laennec Injection,...
06/17/2026, 22:48 ET
Seers Surpasses 200 Adopting Hospitals for ‘thynC,’ Upgrading Operations for Rapid Scaling
Seers, a leading wearable artificial intelligence diagnostic monitoring company, is sharpening its commercial strategy by recruiting a veteran...
06/17/2026, 04:03 ET
Sweet Meets Heat: Why the 'Fricy' Spicy Fruit Trend Is Capturing Global Palates
Travelers returning from Vietnam are increasingly bringing home one must-have culinary souvenir: "shrimp salt.
06/08/2026, 03:46 ET
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs
A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
06/05/2026, 04:24 ET
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and...
06/04/2026, 05:09 ET
Global Appetite for K-Food Drives Record Export Surge as Instant Noodles and Frozen Gimbap Soar
The global spread of Korean pop culture continues to drive unprecedented overseas demand for K-food products, with...
06/02/2026, 02:27 ET
Why Your Summer Tumbler Goes "Pop": Essential Safety and Hygiene Tips for Hot Weather
As summer temperatures climb, personal tumblers become ubiquitous. Many fill them with iced coffee for the morning...
06/02/2026, 02:27 ET
Eli Lilly to Acquire GC Biopharma’s Curevo Vaccine in Blockbuster $1.5 Billion Deal
GC Biopharma’s U.S. affiliate, Curevo Vaccine, is set to be acquired by global pharmaceutical giant Eli Lilly in a deal...
05/30/2026, 05:29 ET
Oscotec Ramps Up R&D: What Lies Beyond the Success of Lazertinib?
“It doesn’t end with lazertinib. Keep an eye out for the next candidate in line.” Oscotec is aggressively channeling...
05/21/2026, 22:00 ET
77 km Linking Sea and River: Busan’s ‘Seven Bridges Tour’ Returns
At 6:30 a. m. , the rhythmic hum of bicycle wheels echoes across Busan’s Gwangandaegyo Bridge.
05/15/2026, 04:44 ET
Previous
3
4
5
6
7
Next